Tumor lysis syndrome after treatment with sorafenib for hepatocellular carcinoma
Crossref DOI link: https://doi.org/10.1007/s13691-014-0186-2
Published Online: 2014-08-17
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kudo, Chieko
Miura, Masahito
Gamoh, Makio
Niitani, Tomohito
Tamagawa, Hiroki
Takahashi, Kiichi
Ichikawa, Sonoko
Sugiyama, Katsuo
Text and Data Mining valid from 2014-08-17